Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

40 Million Americans Now Have New Treatment for Chronic Dental Pain; FDA Approved Proclude First Prophylaxis Paste to Significantly Reduce the Pain of Sensitive Teeth.


Business Editors/Health & Medical Writers

GARDEN CITY, N.Y.--(BW HealthWire)--July 25, 2002

Ortek Announces Launch to Dental Professionals

Ortek Therapeutics Inc. announced today the launch of ProClude(TM) to dental professionals.

ProClude is the first, FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 approved, prophylaxis paste that significantly reduces tooth sensitivity. Prophylaxis pastes are normally applied to teeth by a hygienist or dentist for polishing and stain removal following a dental cleaning. It is estimated that 40 million Americans suffer from tooth sensitivity, making it a major dental health problem.

Tooth sensitivity is a painful condition that consists of short, sharp and frequent jabs of pain when teeth come in contact with cold or hot foods or liquids, cold air and sweet or acidic foods. If left untreated this painful condition can significantly reduce quality of life and lead to pulp death and tooth loss. Additionally, sensitive teeth can lead to patient compliance issues for ongoing dental procedures.

Tooth sensitivity begins with gum recession. Gums recede with aging, aggressive brushing, periodontal disease Periodontal Disease Definition

Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where
 and certain dental procedures. As a result, the tooth's root dentine dentine,
n See dentin.


dentine

one of the hard tissues of the teeth which constitutes most of its bulk. Lies between the pulp cavity and the enamel, and where it is not covered by enamel is covered by cementum, the third hard substance
 can be uncovered when a very thin protective layer, the cementum cementum /ce·men·tum/ (se-men´tum) the bonelike connective tissue covering the root of a tooth and assisting in tooth support.

ce·men·tum
n.
A bonelike substance covering the root of a tooth.
, is removed mechanically or by acidic foods. Microscopic fluid-filled dentinal tubules, now exposed, lead to the tooth's pulp. Oral stimuli can disturb the fluid in the tubules to a point where its movement reaches pulpal nerve fibers causing the sharp pain associated with tooth sensitivity.

ProClude's innovative desensitizing de·sen·si·tize  
tr.v. de·sen·si·tized, de·sen·si·tiz·ing, de·sen·si·tiz·es
1. To render insensitive or less sensitive.

2. Immunology To make (an individual) nonreactive or insensitive to an antigen.
 components, which include the amino acid arginine arginine (är`jənĭn), organic compound, one of the 20 amino acids commonly found in animal proteins. Only the l-stereoisomer participates in the biosynthesis of proteins. , in a unique combination with carbonate-bicarbonate and calcium, forms a paste that plugs and seals the exposed tubules. This process is like spackling a wall that has holes or defects in it. In University-based tests, completely exposed tubules in dentinal den·tin·al
adj.
Of or relating to dentin.


dentinal
(den´tn
 discs treated with ProClude remained sealed even after being bathed in hydrochloric acid for 24 hours Adv. 1. for 24 hours - without stopping; "she worked around the clock"
around the clock, round the clock
. United States and International patents for ProClude have been filed.

"As a periodontist per·i·o·don·tist
n.
A dentist who specializes in periodontics.



periodontist

a dentist who specializes in periodontics.
, one of the unfortunate results of periodontal treatments, both surgical and non-surgical, is tooth sensitivity. I have used many products in attempts to reduce or resolve my patients' post-treatment sensitivity. ProClude is by far the most effective desensitizing agent that I have ever used" said Maria Emanuel Ryan, DDS (1) (Digital Data Storage) See DAT.

(2) (Data Dictionary System) See QuickBuild and OpenDDS.

(3) (Dataphone Digital S
, PhD, Associate Professor, Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York (body) State University of New York - (SUNY) The public university system of New York State, USA, with campuses throughout the state.  at Stony Brook. "My patients have experienced immediate and long-lasting relief of their dental sensitivity with this product."

Two clinical trials evaluating 61 patients with 640 chronic sensitive teeth have been completed. These studies, conducted at a major dental school, have clearly demonstrated ProClude's ability to provide relief of dentinal sensitivity. A four week study testing ProClude's duration after a single application has shown immediate and long-lasting protection. Sensitivity reductions between 84% to 90% remained constant throughout the study period.

"Individuals with sensitive teeth can now enjoy ice cream and their favorite hot or cold beverages without experiencing those agonizing jabs of pain" said Mitchell Goldberg, President of Ortek. "ProClude is a much needed and convenient new therapy. Patients can now be treated simultaneously for dentinal sensitivity while having their teeth cleaned and polished by their dentist or hygienist."

Ortek Therapeutics, Inc. is a fully integrated specialty pharmaceutical company primarily engaged in developing and commercializing proprietary products for the treatment of dental disorders. In addition to ProClude the Company is currently developing additional products for dentinal sensitivity and new therapies for tooth decay, drug resistant infections and cancer. All technology is exclusively licensed by the Company from The Research Foundation of State University of New York, and developed in The Department of Oral Biology and Pathology, State University of N.Y. at Stony Brook.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 25, 2002
Words:604
Previous Article:Voluntary Life Products are the Focus of Eastbridge Consulting Group's Latest Study.
Next Article:Polymedica Reports Record Revenues and Earnings Per Share for the Fiscal First Quarter.



Related Articles
FDA warns health professionals about painkiller's dangers.
Selected Ongoing Clinical Trials [*].
Tooth and Periodontal Disease: A Review for the Primary-Care Physician.
OPEN WIDE: LASER OK'D FOR CAVITIES.
CHECKUP : NEWS, TIPS AND TRENDS WORK-SITE CULTURE, DRINKING LINKED.
New treatment for plantar fasciitis.
FIRM'S SPINAL IMPLANT WINS OK DEVICE DESIGNED TO BE RECHARGED.
NO. 1 KIDS' EPIDEMIC: BAD TEETH.
Addressing dentin hypersensitivity.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles